Details
Product Name in the RMS: Caramlo 8 mg/5 mg Tabletten
MR Number: DE/H/3677/001
Date of outcome: 20.03.2014
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Known Active Substance Initial Application Fixed Combination Chemical Substance Prescription Only |
Active Substances |
amlodipine besilate 6,94 mg candesartancilexetil 8 mg |
Form | Tablet |
MA Holder in the RMS |
Zentiva Pharma GmbH Brüningstr. 50 D-65926 Frankfurt am Main Germany |
RMS | Germany |
Date of last change | 03.12.2020 |
ATC-Code |
C09DB Angiotensin II antagonists and calcium channel blockers |
CMS Country | Domestic Product Name |
---|---|
Bulgaria | Caramlo |
Cyprus | CARAMLO TABS |
Czech Republic | Caramlo 8mg/5mg tablety |
Estonia | ZENICAMO |
Greece | |
Hungary | ZENICAMO 8 mg/5 mg tabletta |
Latvia | |
Lithuania | |
Poland | Caramlo |
Portugal | |
Romania | Caramlo 8 mg/5 mg comprimate |
Documents | |
---|---|
PAR: | DE_H_3677_001_PAR.pdf (29.09.2015) |
FinalSPC: | DE_H_3677_001_FinalSPC.pdf (11.04.2014) |
Finalised Product Information: | DE_H_3677_001_FinalPI_1of2.pdf (17.01.2019) |
Finalised Product Information: | DE_H_3677_001_FinalPI_2of2.pdf (17.01.2019) |